These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease. El Mouzan MI; Korolev KS; Al Mofarreh MA; Menon R; Winter HS; Al Sarkhy AA; Dowd SE; Al Barrag AM; Assiri AA World J Gastroenterol; 2018 Oct; 24(39):4510-4516. PubMed ID: 30356965 [TBL] [Abstract][Full Text] [Related]
5. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study. De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692 [TBL] [Abstract][Full Text] [Related]
6. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. Li Q; Wang C; Tang C; He Q; Li N; Li J J Clin Gastroenterol; 2014 Jul; 48(6):513-23. PubMed ID: 24275714 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease. He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071 [TBL] [Abstract][Full Text] [Related]
8. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522 [TBL] [Abstract][Full Text] [Related]
9. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities. Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344 [TBL] [Abstract][Full Text] [Related]
10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781 [TBL] [Abstract][Full Text] [Related]
11. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease. Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease. Busquets D; Mas-de-Xaxars T; López-Siles M; Martínez-Medina M; Bahí A; Sàbat M; Louvriex R; Miquel-Cusachs JO; Garcia-Gil JL; Aldeguer X J Crohns Colitis; 2015 Oct; 9(10):899-906. PubMed ID: 26142465 [TBL] [Abstract][Full Text] [Related]
14. Transitional and temporal changes in the mucosal and submucosal intestinal microbiota in advanced Crohn's disease of the terminal ileum. Chiodini RJ; Dowd SE; Barron JN; Galandiuk S; Davis B; Glassing A J Med Microbiol; 2018 Apr; 67(4):549-559. PubMed ID: 29458679 [TBL] [Abstract][Full Text] [Related]
15. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers. Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271 [TBL] [Abstract][Full Text] [Related]
16. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery. Mondot S; Lepage P; Seksik P; Allez M; Tréton X; Bouhnik Y; Colombel JF; Leclerc M; Pochart P; Doré J; Marteau P; Gut; 2016 Jun; 65(6):954-62. PubMed ID: 26628508 [TBL] [Abstract][Full Text] [Related]
17. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease. Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A Digestion; 2016; 93(1):59-65. PubMed ID: 26789999 [TBL] [Abstract][Full Text] [Related]
18. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979 [TBL] [Abstract][Full Text] [Related]
19. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies. Khanna S; Raffals LE Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410 [TBL] [Abstract][Full Text] [Related]
20. Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota Recolonisation. Machiels K; Pozuelo Del Río M; Martinez-De la Torre A; Xie Z; Pascal Andreu V; Sabino J; Santiago A; Campos D; Wolthuis A; D'Hoore A; De Hertogh G; Ferrante M; Manichanh C; Vermeire S J Crohns Colitis; 2020 Nov; 14(11):1535-1546. PubMed ID: 32333762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]